CN Patent
CN111777639A — 十六烷氧基丙基膦酸酯的形态
Assigned to Emergency Biological Defense Action Lansing LLC · Expires 2020-10-16 · 6y expired
What this patent protects
本发明描述了膦酸酯化合物的合成方法。根据本发明的方法允许大规模的制备具有高纯度和稳定性的膦酸酯的化合物。还公开了膦酸酯化合物的形态学形态。
USPTO Abstract
本发明描述了膦酸酯化合物的合成方法。根据本发明的方法允许大规模的制备具有高纯度和稳定性的膦酸酯的化合物。还公开了膦酸酯化合物的形态学形态。
Drugs covered by this patent
- Tembexa (BRINCIDOFOVIR) · Emergent Biodefense
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.